RMD - ResMed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RMD is currently covered by 12 analysts with an average price target of $292.36. This is a potential upside of $17.85 (6.5%) from yesterday's end of day stock price of $274.51.

ResMed's activity chart (see below) currently has 100 price targets and 125 ratings on display. The stock rating distribution of RMD is 33.33% HOLD, 64.81% BUY and 1.85% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 71.57% with an average time for these price targets to be met of 172.24 days.

Highest price target for RMD is $290, Lowest price target is $248, average price target is $249.43.

Most recent stock forecast was given by ANTHONY PETRONE from MIZUHO on 16-Jul-2025.

Split History since 2000:

8/31/10 2 for 1

10/3/05 2 for 1

4/3/00 2 for 1

Currently out of the existing stock ratings of RMD, 18 are a HOLD (33.33%), 35 are a BUY (64.81%), 1 are a SELL (1.85%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$270

$-4.51 (-1.64%)

$250

1 months 14 days ago
(16-Jul-2025)

12/12 (100%)

$15.75 (6.19%)

106

Hold

$248

$-26.51 (-9.66%)

$260

4 months 6 days ago
(24-Apr-2025)

3/3 (100%)

$11.9 (5.04%)

70

Buy

$285

$10.49 (3.82%)

$250

4 months 6 days ago
(24-Apr-2025)

6/6 (100%)

$48.9 (20.71%)

42

Buy

$290

$15.49 (5.64%)

$286

4 months 6 days ago
(24-Apr-2025)

18/18 (100%)

$53.9 (22.83%)

353

Hold

6 months 30 days ago
(31-Jan-2025)

11/11 (100%)

$-7.67 (-3.15%)

212

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RMD (ResMed) average time for price targets to be met?

On average it took 172.24 days on average for the stock forecasts to be realized with a an average price target met ratio 71.57

Which analyst has the current highest performing score on RMD (ResMed) with a proven track record?

MATTHEW MISHAN

Which analyst has the most public recommendations on RMD (ResMed)?

Matthew Mishan works at KEYBANK and has 9 price targets and 5 ratings on RMD

Which analyst is the currently most bullish on RMD (ResMed)?

Mike Polark with highest potential upside - $50.08

Which analyst is the currently most reserved on RMD (ResMed)?

Joanne Wuensch with lowest potential downside - -$154.51

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?